Table 3 Reports the prevalence of each HPV genotypes and vaginal infections/TV

pHR/HR HPV Genotype

Frequency (n)

Percentage (N = 616)

95% CI

 HPV 16 (N = 616)

99

16.10%

13.3%–19.2%

 HPV 18 (N = 616)

68

11.04%

08.7%–13.8%

 HPV 31 (N = 616)

49

8.00%

5.9%–10.4%

 HPV 33 (N = 616)

2

0.30%

0.04%–1.2%

 HPV 35 (N = 616)

70

11.40%

9.0%–14.1%

 HPV 39 (N = 616)

48

7.80%

5.8%–10.2%

 HPV 51 (N = 615)

52

8.50%

3.7%–7.4%

 HPV 53 (N = 616)

68

11.04%

8.7%–13.8%

 HPV 56 (N = 616)

45

7.30%

5.4%–9.7%

 HPV 58 (N = 616)

30

4.90%

3.3%–6.9%

 HPV 59 (N = 616)

75

12.20%

9.7%–15.02%

 HPV 66 (N = 616)

60

9.70%

7.5%–12.4%

 HPV 68 (N = 616)

9

4.90%

3.3%–6.9%

 BV (N = 555)

268

48.30%

44.06%–52.5%

 TV (N = 609)

191

31.4%

27.6%–35.2%

 Candida (N = 609)

121

19.90%

16.8%–23.3%